{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:12:02Z","timestamp":1740136322996,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1038\/s41390-022-02019-6","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T11:03:49Z","timestamp":1647342229000},"page":"1598-1599","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Improving neurodevelopmental trajectories after retinopathy of prematurity: challenges and opportunities"],"prefix":"10.1038","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2037-5769","authenticated-orcid":false,"given":"Michael E.","family":"Msall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,15]]},"reference":[{"key":"2019_CR1","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1001\/jama.289.9.1124","volume":"289","author":"B Schmidt","year":"2003","unstructured":"Schmidt, B. et al. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. JAMA 289, 1124\u20131129 (2003).","journal-title":"JAMA"},{"key":"2019_CR2","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1001\/jama.2013.282153","volume":"311","author":"B Schmidt","year":"2014","unstructured":"Schmidt, B., Davis, P. G., Asztalos, E. V., Solimano, A. & Roberts, R. S. Association between severe retinopathy of prematurity and nonvisual disabilities at age 5 years. JAMA 311, 523\u2013525 (2014).","journal-title":"JAMA"},{"key":"2019_CR3","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jpeds.2015.07.067","volume":"167","author":"B Schmidt","year":"2015","unstructured":"Schmidt, B. et al. Prediction of late death or disability at age 5 years using a count of 3 neonatal morbidities in very low birth weight infants. J. Pediatr. 167, 982\u2013986 (2015).","journal-title":"J. Pediatr."},{"key":"2019_CR4","doi-asserted-by":"publisher","first-page":"e1247","DOI":"10.1542\/peds.2010-0806","volume":"127","author":"A Farooqi","year":"2011","unstructured":"Farooqi, A., H\u00e4ggl\u00f6f, B., Sedin, G. & Serenius, F. Impact at age 11 years of major neonatal morbidities in children born extremely preterm. Pediatrics 127, e1247\u2013e1257 (2011).","journal-title":"Pediatrics"},{"key":"2019_CR5","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1542\/peds.106.5.998","volume":"106","author":"ME Msall","year":"2000","unstructured":"Msall, M. E. et al. Severity of neonatal retinopathy of prematurity is predictive of neurodevelopmental functional outcome at age 5.5 years. Behalf of the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Pediatrics 106, 998\u20131005 (2000).","journal-title":"Pediatrics"},{"key":"2019_CR6","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1001\/jama.2015.10244","volume":"314","author":"BJ Stoll","year":"2015","unstructured":"Stoll, B. J. et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 314, 1039\u20131051 (2015).","journal-title":"JAMA"},{"key":"2019_CR7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.clp.2018.05.009","volume":"45","author":"FA Carter","year":"2018","unstructured":"Carter, F. A. & Msall, M. E. Long-term functioning and participation across the life course for preterm neonatal intensive care unit graduates. Clin. Perinatol. 45, 501\u2013527 (2018).","journal-title":"Clin. Perinatol."},{"key":"2019_CR8","doi-asserted-by":"publisher","first-page":"101114","DOI":"10.1016\/j.siny.2020.101114","volume":"25","author":"JL Cheong","year":"2020","unstructured":"Cheong, J. L., Spittle, A. J., Burnett, A. C., Anderson, P. J. & Doyle, L. W. Have outcomes following extremely preterm birth improved over time? Semin. Fetal Neonatal Med. 25, 101114 (2020).","journal-title":"Semin. Fetal Neonatal Med."},{"key":"2019_CR9","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S2352-4642(21)00195-4","volume":"5","author":"N Marlow","year":"2021","unstructured":"Marlow, N. et al. 2-Year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomized controlled trial. Lancet Child Adolesc. Health 5, 698\u2013707 (2021).","journal-title":"Lancet Child Adolesc. Health"},{"key":"2019_CR10","doi-asserted-by":"publisher","first-page":"e20183537","DOI":"10.1542\/peds.2018-3537","volume":"144","author":"G Natarajan","year":"2019","unstructured":"Natarajan, G. et al. Neurodevelopmental outcomes of preterm infants with retinopathy of prematurity by treatment. Pediatrics 144, e20183537 (2019).","journal-title":"Pediatrics"},{"key":"2019_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3928\/23258160-20190605-01","volume":"50","author":"SH Rodriguez","year":"2019","unstructured":"Rodriguez, S. H. et al. Neurodevelopmental outcomes comparing bevacizumab to laser for type 1 ROP. Ophthalmic Surg. Lasers Imaging Retina 50, 337\u2013343 (2019).","journal-title":"Ophthalmic Surg. Lasers Imaging Retina"},{"key":"2019_CR12","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ophtha.2020.11.012","volume":"128","author":"CY Tsai","year":"2021","unstructured":"Tsai, C. Y. et al. Neurodevelopmental outcomes after bevacizumab treatment for retinopathy of prematurity: a meta-analysis. Ophthalmology 128, 877\u2013888 (2021).","journal-title":"Ophthalmology"},{"key":"2019_CR13","doi-asserted-by":"publisher","unstructured":"Brumbaugh, J. E. et al. Relationships between retinopathy of prematurity without ophthalmologic intervention and neurodevelopment and vision at 2 years. Pediatr. Res. https:\/\/doi.org\/10.1038\/s41390-021-01778-y (2021).","DOI":"10.1038\/s41390-021-01778-y"},{"key":"2019_CR14","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1001\/jama.2018.14996","volume":"320","author":"DL Phelps","year":"2018","unstructured":"Phelps, D. L. et al. Effects of myo-inositol on type 1 retinopathy of prematurity among preterm infants <28 weeks\u2019 gestational age: a randomized clinical trial. JAMA 320, 1649\u20131658 (2018).","journal-title":"JAMA"},{"key":"2019_CR15","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1038\/s41372-021-01018-5","volume":"41","author":"I Adams-Chapman","year":"2021","unstructured":"Adams-Chapman, I. et al. Neurodevelopmental outcome of preterm infants enrolled in myo-inositol randomized controlled trial. J. Perinatol. 41, 2072\u20132087 (2021).","journal-title":"J. Perinatol."},{"key":"2019_CR16","doi-asserted-by":"publisher","first-page":"304.e1","DOI":"10.1016\/j.ajog.2016.11.1009","volume":"216","author":"RM Joseph","year":"2017","unstructured":"Joseph, R. M. et al. Extremely low gestational age and very low birthweight for gestational age are risk factors for autism spectrum disorder in a large cohort study of 10-year-old children born at 23-27 weeks\u2019 gestation. Am. J. Obstet. Gynecol. 216, 304.e1\u2013304.e16 (2017).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2019_CR17","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/jnp.12069","volume":"10","author":"CS Molloy","year":"2016","unstructured":"Molloy, C. S., Anderson, P. J., Anderson, V. A. & Doyle, L. W. The long-term outcome of extremely preterm (<28 weeks\u2019 gestational age) infants with and without severe retinopathy of prematurity. J. Neuropsychol. 10, 276\u2013294 (2016).","journal-title":"J. Neuropsychol."},{"key":"2019_CR18","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1097\/IAE.0b013e31821dfa6d","volume":"31","author":"AC Lee","year":"2011","unstructured":"Lee, A. C. et al. Macular features from spectral-domain optical coherence tomography as an adjunct to indirect ophthalmoscopy in retinopathy of prematurity. Retina 31, 1470\u20131482 (2011).","journal-title":"Retina"},{"key":"2019_CR19","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/hbm.24832","volume":"41","author":"CE Kelly","year":"2020","unstructured":"Kelly, C. E. et al. Working memory training and brain structure and function in extremely preterm or extremely low birth weight children. Hum. Brain Mapp. 41, 684\u2013696 (2020).","journal-title":"Hum. Brain Mapp."},{"key":"2019_CR20","doi-asserted-by":"crossref","unstructured":"Msall, M. E., Sobotka, S. A., Dmowska, A., Hogan, D. & Sullivan, M. in Handbook of Life Course Health Development (eds Halfon, N., Forrest, C. B., Lerner, R. M., Faustman, E. M.) 321\u2013348 (Springer, 2018).","DOI":"10.1007\/978-3-319-47143-3_14"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02019-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02019-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02019-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T13:02:35Z","timestamp":1699016555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02019-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,15]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["2019"],"URL":"https:\/\/doi.org\/10.1038\/s41390-022-02019-6","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"type":"print","value":"0031-3998"},{"type":"electronic","value":"1530-0447"}],"subject":[],"published":{"date-parts":[[2022,3,15]]},"assertion":[{"value":"3 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}